Loading clinical trials...
Loading clinical trials...
The investigators will test the central hypothesis that DFO treatment after SAH may improve cerebrovascular regulation, mitigate ischemic neural injury, and serve as an effective neuroprotectant again...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Brigham and Women's Hospital
Collaborators
NCT07250958 · Aneurysmal Subarachnoid Hemorrhage
NCT07294118 · Subarachnoid Hemorrhage, Aneurysmal, Headache, and more
NCT07160088 · Aneurysmal Subarachnoid Hemorrhage (aSAH)
NCT07307508 · Aneurysmal Subarachnoid Hemorrhage (aSAH), Headache Disorders
NCT06119061 · Subarachnoid Hemorrhage, Aneurysmal
Brigham and Women's Hospital
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions